10 Firmen mit Ergebnissen für "immunotherapeutic"

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

10 Ergebnisse für "immunotherapeutic" unter Virometix AG

Microsoft Word - Virometix_Press Release-V-306 Phase I Trial-1st Co...

... biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and ... company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and ... biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and ... company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

24 Ergebnisse für "immunotherapeutic" unter Somagenetix

UZH - CRPP ImmunoCure - Miachael Weller

... immunotherapeutic agents in brain tumors. Furthermore, novel treatment strategies are assessed in patients with ... newly diagnosed and recurrent glioblastoma. Overcoming resistance of gliomas to immunotherapeutic ... chemo- and immunotherapeutic agents in brain tumors. Furthermore, novel treatment strategies are ... immunotherapeutic strategies Development of novel drugs in early clinical trials Design and conductance of late ...

UZH - CRPP ImmunoCure - Patrick Roth

... : University Hospital Zurich Department of Neurology Frauenklinikstrasse 26 CH-8091 Zurich Immunotherapeutic ... the immune system with a particular focus on novel immunotherapeutic strategies. The following ... Department of Neurology Frauenklinikstrasse 26 CH-8091 Zurich patrick.roth@usz.ch Immunotherapeutic ... the immune system with a particular focus on novel immunotherapeutic strategies. The following ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

16 Ergebnisse für "immunotherapeutic" unter University of Zurich

UZH - CRPP ImmunoCure

... immunotherapeutic strategies for various types of cancer including brain tumors and hematological malignancies. A ... groups aiming at the development of novel immunotherapeutic strategies for various types of cancer ... CAR T cells and other antibody-based immunotherapeutic strategies in appropriate preclinical models ...

Frequent PD-L1 expression in testicular germ cell tumors - Zurich O...

... immunotherapeutic strategies. METHODS Immunohistochemistry was performed in 479 formalin-fixed paraffin-embedded ... immunotherapeutic strategies using anti-PD1 and anti-PDL1 antibodies. Abstract BACKGROUND Many testicular germ cell ... immunotherapeutic strategies. METHODS Immunohistochemistry was performed in 479 formalin-fixed paraffin-embedded ... immunotherapeutic strategies using anti-PD1 and anti-PDL1 antibodies. Abstract BACKGROUND Many testicular germ cell ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

19 Ergebnisse für "immunotherapeutic" unter University Hospital Zurich​, Research and Education Office

5th Zurich Immuno-Oncology Symposium – Universitätsspital Zürich

... development of new immunotherapeutic agents requires a multidisciplinary approach. Standort 16.30-18:30 Uhr ... development of new immunotherapeutic agents requires a multidisciplinary approach. Standort Virtual Live ...

New Portfolio Start-Up: Stromal Therapeutics – USZ

... stroma. Stromal Therapeutics is developing novel Immunotherapeutic medicines to treat chronic ... developing novel Immunotherapeutic medicines to treat chronic inflammatory diseases. With their unique domain ...

Mehr Ergebnisse

ImmunOs Therapeutics AG

http://immunostherapeutics.com/  

8952 Schlieren, Wagistrasse 14


 info@immunostherapeutics.com

ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.

ImmunOs Therapeutics AG

Wagistrasse 14

8952 Schlieren

3 Ergebnisse für "immunotherapeutic" unter ImmunOs Therapeutics AG

Company

... mission is to convert first-in-class immunotherapeutic targets into exploitable drug candidates. Our team ... . ImmunOs Therapeutics AG mission is to convert first-in-class immunotherapeutic targets into exploitable ...

Scientific Advisory Board - Immunostherapy

... immunotherapeutic antibodies based on novel targets and preclinical reagents originating at MD Anderson. He also has ... , which coordinates development and production of clinical immunotherapeutic antibodies based on novel ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

2 Ergebnisse für "immunotherapeutic" unter InSphero AG

... Presentation: A three-dimensional ex vivo platform for assessing targeted immunotherapeutic agents   Phone : +1 ...

... Applications ▬ Assess tumor cell killing and investigate immunotherapeutic efficacy of single drugs or ... Applications ▬ Assess tumor cell killing and investigate immunotherapeutic efficacy of single drugs or ...

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2 Ergebnisse für "immunotherapeutic" unter Roche Glycart AG

VENTANA MMR RxDx Panel (CE IVD)

... immunotherapeutic option for patients.8 Multiple studies have demonstrated that MMR deficiency correlate with higher ... deficiency serves as a predictive biomarker for a new immunotherapeutic option for patients. 8 Multiple ...

VENTANA MMR RxDx Panel (US FDA Approved)

...  eLabDoc. MMR deficiency serves as a predictive biomarker for a new immunotherapeutic option for patients.1 ...   eLabDoc . Visit eLabDoc MMR deficiency serves as a predictive biomarker for a new immunotherapeutic option ...

NEXUS Personalized Health Technologies

https://www.nexus.ethz.ch/  

8952 Schlieren, Wagistrasse 18

 +41 44 632 21 61
 stekhoven@nexus.ethz.ch

NEXUS Personalized Health Technologies is an ETH Technology Platform created to enable and accelerate the execution of translational research projects by providing key technological resources, tools and collaboration opportunities for the personalized health research community. NEXUS is built around two interdisciplinary technology units that are staffed with professional scientists: Theragnostics Discovery and Clinical Bioinformatics.

NEXUS Personalized Health Technologies

Wagistrasse 18

8952 Schlieren

1 Ergebnisse für "immunotherapeutic" unter NEXUS Personalized Health Technologies

NEXUS User Seminar – NEXUS Personalized Health Technologies | ETH Zurich

... alternative splicing in generating tumor markers that are targetable with immunotherapeutic approaches. After ... immunotherapeutic approaches. After translating all RNA-sequences generated by novel introns into protein space, we ...

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

1 Ergebnisse für "immunotherapeutic" unter Blutspende SRK Zürich

Mapping naturally presented T cell antigens in medulloblastoma base...

... immunotherapeutic approaches to children with medulloblastoma. Central nervous system (CNS) tumors remain the ... immunotherapeutic approaches to children with medulloblastoma. Central nervous system (CNS) tumors remain the ...

CDR-Life AG

http://cdr-life.com/  

8810 Horgen, Tödistrasse 46


 info@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

CDR-Life AG

Tödistrasse 46

8810 Horgen

1 Ergebnisse für "immunotherapeutic" unter CDR-Life AG

News - CDR-Life

... most challenging malignancies with a novel immunotherapeutic approach.” About CDR-Life CDR-Life ... most challenging malignancies with a novel immunotherapeutic approach.” About CDR-Life CDR-Life ...

Nach oben